Santen Pharmaceutical Co. Ltd. | Ownership
Companies that own Santen Pharmaceutical Co. Ltd.
Massachusetts Financial Services Co.
42,305,550
10.39%
2,989,800
0.21%
07/07/2017
MFS International (UK) Ltd.
21,971,445
5.4%
40,945
0.71%
07/31/2018
Nomura Asset Management Co., Ltd.
9,727,795
2.39%
-359,824
0.09%
07/31/2018
Black Creek Investment Management, Inc.
9,193,111
2.25%
9,193,111
2%
06/30/2017
The Vanguard Group, Inc.
8,919,285
2.19%
50,800
0%
07/31/2018
National Mutual Insurance Fed. of Agricultural Cooperatives
7,121,000
1.75%
0
0.95%
09/30/2017
BlackRock Fund Advisors
5,703,600
1.4%
-9,400
0%
09/06/2018
Schroder Investment Management Ltd.
4,616,300
1.12%
-229,100
0.05%
07/31/2018
Schroder Investment Management (Japan) Ltd.
4,086,538
1%
-71,362
0.86%
05/31/2018
Daiwa Asset Management Co. Ltd.
3,489,999
0.86%
-262,601
0.06%
07/31/2018
| Address |
Grand Front Osaka Tower A, 25/F
Osaka Osaka 530
Japan
|
|
Employees
|
- |
| Website |
http://www.santen.co.jp |
| Updated |
07/08/2019 |
| Santen Pharmaceutical Co., Ltd engages in the manufacture and sale of pharmaceutical products and medical devices. It operates through the Pharmaceuticals and Other segments. The Pharmaceuticals segment includes prescription ophthalmic drugs, anti-rheumatic pharmaceuticals, and over-the-counter products. |
